DUBLIN, Feb. 26, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced financial and operational...
Contacts TaskUs Media contact: Heidi.Lemmetyinen@taskus.com TaskUs, Inc. (Nasdaq: TASK), a leading provider of outsourced digital services and next-generation customer experience...
NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Talkspace (Nasdaq: TALK), a leading behavioral healthcare company, today announced that management...
Generates Double-Digit Sales Growth and Continuing Profitability ICL Sales Up 22% in Fourth Quarter and 18% in Fiscal 2023 Affirms...
–Amends certain financial covenants to enhance liquidity and financial flexibility– –Ensures alignment with the Company’s current and future business operations–Read more...
Contacts Investor Contact James Baglanis IR@sonos.com Media Contact Erin Pategas PR@sonos.com Sonos, Inc. (Nasdaq: SONO) today announced that Patrick Spence,...
Sixth Straight Quarter of Record Revenue Culminates in 35% Growth Year for Fiscal 2023 Contacts SkyWater Investor Contact: Claire McAdams...
Contacts Mark DeRussy, CFA Capital Markets 561-226-9531 Lynne Hopkins Media Relations 561-226-9431 SBA Communications Corporation (Nasdaq: SBAC) ("SBA" or the...
REDWOOD CITY, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted...
CAMBRIDGE, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the...
Advancing leading pipeline of six disclosed programs across AAV cardiovascular and LV hematology portfolios; all milestones remain on track for...
Q4 2023 revenue and adjusted EBITDA significantly exceeded guidance;Revenue growth accelerated to $84.6 million, up 14% over Q4 2022, delivered...
BURLINGTON, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Progress Software Corporation (NASDAQ: PRGS) (“Progress”) today announced that it intends to...
LOS ANGELES, Feb. 26, 2024 (GLOBE NEWSWIRE) -- PLBY Group, Inc. (Nasdaq: PLBY) (the “Company” or “PLBY Group”), a leading...
CINCINNATI, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of...
MENLO PARK, Calif., Feb. 26, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced...
COLUMBUS, Ohio, Feb. 26, 2024 /PRNewswire/ -- Northwest Bancshares, Inc. (Nasdaq: NWBI) and its wholly-owned subsidiary Northwest Bank announced today...
RADNOR, Pa., Feb. 26, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), ("NRx Pharmaceuticals" or the "Company"), a clinical-stage biopharmaceutical...
Results for the Quarter and Fiscal Year Ended December 31, 2023 and Other Recent Highlights:NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE)...
NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Mercer International Inc. ("Mercer" or the "Company") (Nasdaq: MERC) announced that Jimmy...
SOUTH SAN FRANCISCO, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company...
— Adds efficient PCIe® to JESD interface bridge to enable low power acceleration for 5G datapath applications — Contacts MEDIA...
NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic...
2023 Annual Net Revenue Exceeds $1 Billion for Third Consecutive Year Record Annual Net Revenue for On-Demand Talent and Heidrick...
Contacts Investor Contact Spencer Kurn SVP, Investor Relations +1 401-225-0475 spencer.kurn@ftr.com Media Contact Chrissy Murray VP, Corporate Communications +1 504-952-4225...
LIVERMORE, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- FormFactor, Inc. (Nasdaq: FORM) is pleased to announce the closing of its...
Contacts Investor Relations Contacts: Five9, Inc. Barry Zwarenstein Chief Financial Officer 925-201-2000 ext. 5959 IR@five9.com The Blueshirt Group for Five9,...
CIRM Grant Awarded to Support Phase 1 Autoimmunity Study of FT819 CD19-targeted CAR T-cell Program for Systemic Lupus Erythematosus; Study...
Contacts Everbridge: Investors: Nandan Amladi Investor Relations nandan.amladi@everbridge.com 617-665-7197 Media: Jeff Young Media Relations jeff.young@everbridge.com 781-859-4116 Everbridge, Inc. (Nasdaq: EVBG),...
FORT MYERS, Fla., Feb. 26, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), one of...
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER...
LONDON, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access...
4Q’23 Marketplace Revenue further accelerated to 10% YoY, fastest pace in 10 quarters4Q'23 Consolidated Net Loss of $(22.6) million, down...
WATKINSVILLE, Ga., Feb. 26, 2024 /PRNewswire/ -- Oconee Financial Corporation ("Oconee") (OTCQX: OSBK) announced that the Company's Board of Directors...
Uitgebreid Telecom-platform met maximale keuze uit toepassingsgeoptimaliseerde servers leveren verbeterde output en energie-efficiëntie - aanbod van open en multi-architectuur opties,...
Contacts W. Mark Tatterson Chief Financial Officer (800) 445-1347 United Bankshares, Inc. (NASDAQ: UBSI) today announced that its Board of...
PHOENIX, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Cavco Industries, Inc. (Nasdaq: CVCO) announced today that the first homes have been...
Contacts Sharon Taylor Chief Financial Officer (877) 256-6644 investor.relations@mmlp.com Martin Midstream Partners L.P. (NASDAQ: MMLP) (“MMLP”) today provided an update...
TORONTO, ON / ACCESSWIRE / February 26, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company...
-Lucid sigue adelante: el fabricante americano presenta en Ginebra nuevos coches eléctricos y planes de expansión para Europa GINEBRA, 26...
